Escorp Asset Management Limite (ESCORP.BO)
INR 58.75
(0.0%)
INR 58.75
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 166.9 Million | 15.49 Million | 61.28 Million | 671 Thousand | -330 Thousand | 1.01 Million |
| Net Income | 172.52 Million | 17.55 Million | 58.56 Million | 27 Thousand | 31 Thousand | -759 Thousand |
| Depreciation & Amortization | - | - | - | 4000.00 | 44 Thousand | 55 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -689 Thousand | -842 Thousand | -316 Thousand | 396 Thousand | -306 Thousand | 1.79 Million |
| Other non-cash items | -4.93 Million | -857 Thousand | 3.33 Million | -881 Thousand | 1.2 Million | 83 Thousand |
| Investing Cash Flow | -87.8 Million | 7.59 Million | -20.78 Million | -212 Thousand | 312 Thousand | -1.72 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -94.15 Million | - | -20.78 Million | -212 Thousand | - | -24.72 Million |
| Sales/Maturities of investments | - | 7.59 Million | - | - | 312 Thousand | 23 Million |
| Other Investing Activities | -87.8 Million | 10.38 Million | -19.83 Million | 2000.00 | 533 Thousand | -24.23 Million |
| Financing Cash Flow | - | -10 Thousand | -2000.00 | -2000.00 | -3000.00 | -3000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -10 Thousand | -2000.00 | -2000.00 | -3000.00 | -3000.00 |
| Accounts receivables | 245 Thousand | -421 Thousand | -295 Thousand | 1.13 Million | -1.24 Million | 82 Thousand |
| Accounts payables | 68 Thousand | 62 Thousand | 1000.00 | - | 28 Thousand | -127 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -934 Thousand | -483 Thousand | -22 Thousand | -737 Thousand | 913 Thousand | 1.83 Million |
| Cash at beginning of period | 67.31 Million | 8.22 Million | 718 Thousand | 258 Thousand | 275 Thousand | 988 Thousand |
| Cash at end of period | 146.41 Million | 1.61 Million | 8.22 Million | 718 Thousand | 258 Thousand | 275 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | 11 Thousand | 2000.00 | 24 Thousand | -17 Thousand | - |
| Net cash flow / Change in cash | 79.09 Million | -6.6 Million | 7.5 Million | 460 Thousand | -17 Thousand | -713 Thousand |
| Free Cash Flow | 166.9 Million | 15.49 Million | 61.28 Million | 671 Thousand | -330 Thousand | 1.01 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 172.52 Million | 12.1 Million | 12.1 Million | 148.31 Million | 74.15 Million | 17.55 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -622 Thousand | 35.42 Million | 35.42 Million | -71.53 Million | -35.76 Million | -842 Thousand |
| Other non-cash items | 1.04 Million | -9.78 Million | -9.78 Million | 15.82 Million | 7.31 Million | -857 Thousand |
| Investing Cash Flow | -94.15 Million | 1.99 Million | 1.99 Million | -93.75 Million | -45.89 Million | 7.59 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -94.15 Million | -403 Thousand | - | -93.75 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 7.59 Million |
| Other Investing Activities | -87.8 Million | 1.99 Million | 1.99 Million | -45.89 Million | -45.89 Million | 10.38 Million |
| Financing Cash Flow | - | - | - | - | - | -10 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -10 Thousand |
| Accounts receivables | 245 Thousand | -259.5 Thousand | -259.5 Thousand | 764 Thousand | 382 Thousand | -421 Thousand |
| Accounts payables | 68 Thousand | 63 Thousand | - | 5000.00 | - | 62 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -935 Thousand | 35.68 Million | 35.68 Million | -72.3 Million | -36.15 Million | -483 Thousand |
| Cash at beginning of period | 1.61 Million | 1.24 Million | - | 1.61 Million | - | 8.22 Million |
| Cash at end of period | 10.41 Million | 10.41 Million | 39.73 Million | 1.24 Million | -187.5 Thousand | 1.61 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | 11 Thousand |
| Net cash flow / Change in cash | 8.79 Million | 9.17 Million | 39.73 Million | -375 Thousand | -187.5 Thousand | -6.6 Million |
| Free Cash Flow | 173.25 Million | 37.74 Million | 37.74 Million | 93.38 Million | 45.71 Million | 15.49 Million |
5512
STOVACQ
ARBB
CAAOF
SOBR
FDA